Our Pricing

PPI Dosage Comparison: Lansoprazole vs Omeprazole

Understanding lansoprazole vs omeprazole dosage UK equivalence is essential when choosing the right proton pump inhibitor for acid reflux. At Cured Pharmacy, our UK-registered clinical team helps patients navigate PPI options with transparent pricing from £9.99, ensuring you receive the most appropriate treatment following a free online consultation with a qualified prescriber.

How Lansoprazole and Omeprazole Work as PPIs

Both lansoprazole and omeprazole belong to the proton pump inhibitor (PPI) class of medications, working by irreversibly blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells [1]. This mechanism reduces stomach acid production by up to 90%, providing relief from gastro-oesophageal reflux disease (GORD), peptic ulcers, and dyspepsia.

Despite their similar mechanism, these PPIs differ in their chemical structure and pharmacokinetic profiles. Lansoprazole is absorbed more rapidly than omeprazole, reaching peak plasma concentrations within 1.5 to 2 hours compared to omeprazole's 2 to 4 hours [2]. Both medications require activation in the acidic environment of parietal cells and have a duration of action lasting 24 hours, making once-daily dosing appropriate for most patients.

The MHRA has licensed both medications for short-term treatment of reflux symptoms and long-term management of conditions requiring sustained acid suppression. All PPI treatments available at Cured Pharmacy require clinical assessment by a UK prescriber to ensure appropriate use and dosing.

Lansoprazole vs Omeprazole Dosage Equivalence

The standard therapeutic doses are not directly equivalent milligram-for-milligram. Clinical evidence suggests that lansoprazole 30mg provides comparable acid suppression to omeprazole 20mg, making lansoprazole approximately 1.5 times more potent on a weight basis [3]. This difference in potency stems from lansoprazole's faster absorption and slightly higher bioavailability.

For gastro-oesophageal reflux disease, the typical starting dose is omeprazole 20mg once daily or lansoprazole 30mg once daily, taken before food. In cases requiring more intensive acid suppression, such as Zollinger-Ellison syndrome or severe erosive oesophagitis, doses may be increased to omeprazole 40mg or lansoprazole 60mg daily, subject to prescriber assessment [4].

When switching between these PPIs, your UK prescriber will consider your response to previous treatment, symptom severity, and any underlying conditions. Some patients who experience incomplete symptom control on omeprazole 20mg may achieve better results with lansoprazole 30mg, though individual responses vary considerably.

Standard Dosing Regimens for Common Conditions

For uncomplicated GORD, both medications are typically prescribed for 4 to 8 weeks initially. Omeprazole is available in 10mg and 20mg strengths, with the lower dose suitable for mild symptoms or maintenance therapy. Lansoprazole comes in 15mg and 30mg capsules, with 15mg often used for maintenance once acute symptoms resolve [1][3].

Patients with H. pylori eradication therapy receive higher doses as part of combination treatment with antibiotics. The standard regimen includes omeprazole 20mg or lansoprazole 30mg twice daily for 7 days, alongside clarithromycin and amoxicillin or metronidazole, achieving eradication rates of approximately 85% in clinical trials [5].

Which Is Stronger: Lansoprazole or Omeprazole?

When comparing acid suppression capacity, lansoprazole demonstrates slightly greater potency per milligram than omeprazole. Studies measuring intragastric pH levels show that lansoprazole 30mg maintains pH above 4 for approximately 13 to 15 hours daily, compared to 11 to 13 hours with omeprazole 20mg [2][6]. This modest difference may benefit patients with nocturnal reflux symptoms or those requiring more sustained acid control.

However, clinical effectiveness depends on multiple factors beyond raw potency. Patient genetics, particularly CYP2C19 enzyme polymorphisms, significantly influence PPI metabolism. Approximately 2-5% of the UK population are rapid metabolisers who break down PPIs quickly, potentially experiencing reduced efficacy with standard doses [3]. In such cases, switching between PPIs or adjusting timing may improve outcomes.

Neither medication is universally 'stronger' for all patients. Some individuals respond better to omeprazole, whilst others achieve superior symptom control with lansoprazole. Your UK prescriber at Cured Pharmacy will consider your medical history, previous PPI response, and concurrent medications when recommending the most appropriate option.

Switching from Omeprazole to Lansoprazole

Patients may switch between PPIs for various reasons, including incomplete symptom relief, side effects, or cost considerations. When transitioning from omeprazole to lansoprazole, the standard conversion is omeprazole 20mg to lansoprazole 30mg, maintaining equivalent acid suppression [4]. This switch can be made immediately without tapering, as both medications work through the same mechanism.

Some patients report improved symptom control after switching, though this may reflect natural disease variation rather than superior efficacy. A study comparing PPI switching patterns found that approximately 15-20% of patients who switched from omeprazole to lansoprazole reported better reflux control, whilst similar proportions experienced improvement when switching in the opposite direction [6].

If you're considering switching PPIs, discuss this with your prescriber during your online consultation. Cured Pharmacy offers both lansoprazole and omeprazole with transparent pricing, allowing you to access the most suitable treatment without financial barriers. All switches require clinical approval to ensure safety and appropriateness.

Timing and Administration Differences

Both PPIs should be taken 30 to 60 minutes before food for optimal absorption and effectiveness. Lansoprazole capsules can be opened and the granules mixed with soft food or fruit juice if swallowing difficulties exist, whilst maintaining efficacy. Omeprazole capsules should generally be swallowed whole, though dispersible formulations are available for patients with dysphagia.

For patients taking PPIs twice daily, doses should be administered before breakfast and dinner. Consistent timing enhances acid suppression and symptom control. Missing occasional doses is unlikely to cause immediate symptom return, but regular adherence is essential for maintaining therapeutic benefit.

Side Effects and Safety Considerations

Both lansoprazole and omeprazole share similar safety profiles, with most patients tolerating them well. Common side effects include headache (affecting 2-5% of users), gastrointestinal disturbances such as nausea, diarrhoea, or constipation, and abdominal pain [1][4]. These effects are generally mild and resolve with continued use or dose adjustment.

Long-term PPI use, typically defined as continuous treatment exceeding 12 months, has been associated with potential risks including reduced magnesium absorption, increased fracture risk, and small intestinal bacterial overgrowth. The MHRA recommends using the lowest effective dose for the shortest duration necessary [5]. Your UK prescriber will review your treatment regularly to assess ongoing need and consider step-down therapy when appropriate.

Drug interactions warrant attention with both PPIs. They may reduce absorption of medications requiring acidic environments, such as ketoconazole and itraconazole, and can interact with clopidogrel, reducing its antiplatelet effect. Lansoprazole and omeprazole are metabolised by the CYP2C19 enzyme system, potentially interacting with warfarin, phenytoin, and certain antidepressants [2][3]. Always disclose all medications during your online consultation.

Accessing Lansoprazole and Omeprazole at Cured Pharmacy

Cured Pharmacy offers both lansoprazole and omeprazole with transparent upfront pricing and no hidden fees. Our omeprazole capsules start from £9.99, whilst lansoprazole is available from £9.99, providing accessible treatment options for acid reflux management. All prices are displayed before your free online consultation, ensuring complete transparency.

Our UK-registered clinical team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), conducts thorough assessments to determine the most appropriate PPI for your individual needs. The online consultation takes under three minutes and covers your medical history, current symptoms, and treatment goals. Following prescriber approval, your medication is dispensed from our GPhC-registered pharmacy (9012511) and delivered in 100% discreet packaging.

We stock genuine UK-licensed medications only, including branded options such as Losec (omeprazole) from £9.99 and Zoton FasTab (lansoprazole) from £9.99 for patients preferring branded formulations. Alternative PPIs including esomeprazole and pantoprazole are also available, providing comprehensive choice for acid reflux treatment. Start your assessment today to access expert care and competitive UK pricing.

Why Choose Cured Pharmacy for PPI Treatment

Our commitment to transparent pricing means you'll never encounter unexpected costs. Unlike traditional pharmacy models, we display exact prices before consultation, allowing informed treatment decisions. Our lowest prices guarantee ensures you're receiving competitive rates across all PPI medications.

Every prescription undergoes review by UK-registered prescribers who assess suitability based on current NICE and MHRA guidelines. We offer free delivery on qualifying orders and maintain strict confidentiality throughout the process. For questions about lansoprazole vs omeprazole dosage or any aspect of acid reflux treatment, our pharmacy team is available at (+44) 116 4646009.

Scientific References

1. Stedman, C. A., & Barclay, M. L. (2000). Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963-978. https://doi.org/10.1046/j.1365-2036.2000.00788.x
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C19 polymorphisms. Clinical Pharmacology & Therapeutics, 85(3), 296-301. https://doi.org/10.1038/clpt.2008.222
3. Scholten, T., & Dekkers, C. P. (2000). Lansoprazole: a clinical review. Drugs of Today, 36(4), 237-254. https://doi.org/10.1358/dot.2000.36.4.570204
4. National Institute for Health and Care Excellence. (2019). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184). NICE. https://www.nice.org.uk/guidance/cg184
5. Medicines and Healthcare products Regulatory Agency. (2012). Proton pump inhibitors in long-term use: reports of hypomagnesaemia. Drug Safety Update, 5(11), A1. https://www.gov.uk/drug-safety-update/proton-pump-inhibitors-in-long-term-use-reports-of-hypomagnesaemia
6. Gralnek, I. M., et al. (2000). Comparison of lansoprazole and omeprazole in the treatment of erosive oesophagitis: a prospective, randomised trial. Alimentary Pharmacology & Therapeutics, 14(8), 963-978. https://doi.org/10.1046/j.1365-2036.2000.00795.x

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.